Jacob Thomas Selected Research

Eczematous Skin Diseases

9/2022

Tofacitinib in the treatment of refractory eczemas - a case series.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jacob Thomas Research Topics

Disease

2	Alopecia Areata 09/2022 - 04/2015
2	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2022 - 11/2021
2	Skin Diseases (Skin Disease) 09/2022 - 07/2022
2	Hyperpigmentation 11/2021 - 09/2015
2	Cystic Fibrosis (Mucoviscidosis) 01/2021 - 01/2021
2	Persistent Infection 01/2021 - 01/2021
2	Neuroinflammatory Diseases 11/2012 - 04/2012
2	Neoplasms (Cancer) 11/2012 - 08/2008
1	Eczematous Skin Diseases 09/2022
1	Vitiligo 09/2022
1	Atopic Dermatitis (Atopic Eczema) 09/2022
1	Dermatitis 09/2022
1	Bullous Pemphigoid (Pemphigoid) 07/2022
1	Granuloma 11/2021
1	Drug Resistant Epilepsy 10/2021
1	Vision Disorders (Hemeralopia) 10/2021
1	CDKL5 deficiency disorder 10/2021
1	Neurodevelopmental Disorders 10/2021
1	Infections 01/2021
1	Critical Illness (Critically Ill) 08/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Granuloma Annulare 05/2017
1	Chromoblastomycosis (Chromomycosis) 03/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2015
1	Hypopigmentation (Hypomelanosis) 09/2015
1	Blepharophimosis 04/2015
1	Hyperalgesia 01/2015
1	Pain (Aches) 01/2015
1	Starvation 01/2015
1	Lung Diseases (Lung Disease) 01/2013
1	Intracranial Aneurysm (Cerebral Aneurysm) 11/2012
1	Aneurysm (Aneurysms) 11/2012
1	Anemia 11/2012
1	Transient Ischemic Attack 11/2012
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2012
1	Chronic Pain 11/2012
1	Stroke (Strokes) 11/2012
1	Neoplasm Metastasis (Metastasis) 11/2012

Drug/Important Bio-Agent (IBA)

2	Opioid Receptors (Opioid Receptor)IBA 01/2015 - 04/2012
2	Opioid Analgesics (Opioids)IBA 01/2015 - 11/2012
1	tofacitinibIBA 09/2022
1	Janus Kinase InhibitorsIBA 09/2022
1	SteroidsIBA 09/2022
1	Dipeptidyl-Peptidase IV InhibitorsIBA 07/2022
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 07/2022
1	MercuryIBA 11/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	MucinsIBA 01/2021
1	PolymersIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Bacteriocins (Lantibiotics)IBA 01/2021
1	AntigensIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	O Antigens (O Antigen)IBA 01/2021
1	PyocinsIBA 01/2021
1	DiureticsIBA 08/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Glycerol (Glycerine)FDA LinkGeneric 01/2020
1	HydrolasesIBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Monoacylglycerol LipasesIBA 01/2020
1	Arachidonic Acid (Vitamin F)IBA 01/2020
1	EndocannabinoidsIBA 01/2020
1	Pentoxifylline (Trental)FDA LinkGeneric 05/2017
1	CopperIBA 03/2016
1	Tyrosine Kinase InhibitorsIBA 09/2015
1	Imatinib Mesylate (Gleevec)FDA Link 09/2015
1	diphenylcyclopropenoneIBA 04/2015
1	Analgesics (Analgesic Drugs)IBA 01/2015
1	Transcription Factors (Transcription Factor)IBA 01/2015
1	GTP-Binding Proteins (G-Protein)IBA 01/2015
1	ChitinIBA 01/2015
1	pyrimidineIBA 01/2015
1	CytokinesIBA 01/2013
1	AdipokinesIBA 01/2013
1	GuaiacIBA 11/2012
1	Clopidogrel (Plavix)FDA Link 11/2012
1	EndotoxinsIBA 04/2012
1	Morphine (MS Contin)FDA LinkGeneric 04/2012
1	Complement System Proteins (Complement)IBA 08/2008

Therapy/Procedure

5	Therapeutics 09/2022 - 11/2012
1	Drug Substitution 07/2022
1	Complementary Therapies (Alternative Medicine) 01/2021
1	Immunotherapy 04/2015
1	Stents 11/2012
1	Gastrostomy 11/2012